Philip J Cowen MD FRCPsych
 MRC Clinical Scientist and Honorary Consultant
Psychiatrist, Department of Psychiatry, Oxford.
Elected to a personal chair in
psychopharmacology at Oxford University in 1997.
Professor Cowen's main interests are in
the biochemistry and treatment of mood disorders, particularly the
pharmacological management of resistant depression. His group has
special expertise in the use of pharmacological challenge tests to
assess the effects of both mood disorder and antidepressant
treatments on brain serotonin function. More recently, in
collaboration with Professor Paul Grasby at the MRC Cyclotron
Unit, the group has been able to use ligand PET imaging to
assess the role of brain 5-HT1A receptors in
vulnerability to mood disorder and the mechanism of antidepressant
action.
Email: phil.cowen@psych.ox.ac.uk
Declaration of interest:
Professor Cowen has acted as an advisor to Eli Lilly,
GlaxoSmithKline and Lundbeck, Servier, Wyeth.
|